Drugplain

ELEVIDYS

delandistrogene moxeparvovec-rokl · KIT · Sarepta Therapeutics, Inc.

No Recall History
Plain English

Elevidys is a prescription gene therapy given as an intravenous infusion used to treat certain forms of muscular dystrophy. It works by delivering a functional gene to help muscles produce the proteins needed for proper muscle function.

Key Facts

Brand Name
ELEVIDYS
Generic Name
delandistrogene moxeparvovec-rokl
NDC Code (Product)
60923-550
Manufacturer
Sarepta Therapeutics, Inc.
Dosage Form
KIT
Route
INTRAVENOUS
Marketing Status
Application #
BLA125781
Marketing Start
06/22/2023

Recall History

No Recall History

Frequently Asked Questions

What is ELEVIDYS used for?

Elevidys is a prescription gene therapy given as an intravenous infusion used to treat certain forms of muscular dystrophy. It works by delivering a functional gene to help muscles produce the proteins needed for proper muscle function.

Is ELEVIDYS a controlled substance?

ELEVIDYS is not classified as a controlled substance by the DEA.

What is the generic name for ELEVIDYS?

The generic name for ELEVIDYS is delandistrogene moxeparvovec-rokl. There are no other listed brand versions of delandistrogene moxeparvovec-rokl.

What is the NDC code for ELEVIDYS ?

The NDC (National Drug Code) for ELEVIDYS is 60923-550, listed by Sarepta Therapeutics, Inc..

Product NDC

60923-550

Package NDC

60923-550-59

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)